Sudhakar Padmaja, Acharya Kishor, Kini Tonse Ashwini
Department of Neurology and Ophthalmology, University of Kentucky, Lexington, KY, United States.
Centennial Neuroscience, Nashville, TN, United States.
Front Neurol. 2025 Sep 11;16:1626909. doi: 10.3389/fneur.2025.1626909. eCollection 2025.
Ethambutol is an antitubercular drug that is commonly used in the areas of the world that is endemic to tuberculosis. It is used in infections caused by and some non-tuberculous infections caused by Mycobacterium species. Ethambutol related toxic optic neuropathy remains one of the most concerning adverse effects of the medication in addition to other non-specific side effects like peripheral neuropathy, nausea, vomiting, joint pain and rash. Recently the guidelines for treatment of tuberculosis in some countries where tuberculosis (TB) is endemic have been revised to allow for fixed dose combinations (wherein a single tablet contains a fixed strength of isoniazid, rifampicin, pyrazinamide, and ethambutol) and longer duration of treatment with ethambutol. Thus, it is anticipated that there will be an increase in ethambutol toxic optic neuropathy. In this minireview we plan to discuss the clinical features, neuro-ophthalmic evaluation, screening and diagnosis of ethambutol toxic optic neuropathy. We will also discuss the available treatment options for this condition.
乙胺丁醇是一种抗结核药物,常用于世界上结核病流行的地区。它用于治疗由结核分枝杆菌引起的感染以及一些由分枝杆菌属引起的非结核感染。除了外周神经病变、恶心、呕吐、关节疼痛和皮疹等其他非特异性副作用外,乙胺丁醇相关的毒性视神经病变仍然是该药物最令人担忧的不良反应之一。最近,在一些结核病流行国家,结核病治疗指南已修订,允许使用固定剂量复方制剂(其中一片药含有固定剂量的异烟肼、利福平、吡嗪酰胺和乙胺丁醇),并延长乙胺丁醇的治疗时间。因此,预计乙胺丁醇毒性视神经病变将会增加。在本综述中,我们计划讨论乙胺丁醇毒性视神经病变的临床特征、神经眼科评估、筛查和诊断。我们还将讨论针对这种情况的现有治疗选择。